Swiss medical device company

Johnson & Johnson (NYSE: JNJ), a leading healthcare and pharmaceutical company, is expected to complete the acquisition of Swiss medical device company on Thursday. The acquisition, expected to cost $19.7 billion, will be Johnson & Johnson's largest deal in history. The purchase will be...